Browse by Clinical Topic:


Featured CME/CE Content:
 
neuroscienceCME Editors' Picks:



ADHD Across the Ages: Focus on the Adult

neuroscienceCME Live and On Demand

Premiere Date: Wednesday, December 2, 2009

Click here to access additional resources mentioned in the live broadcast.

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. Psychologists (APA)
  5. Social Workers (NASW)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Wednesday, March 2, 2011

Faculty


David A. Baron, MSEd, DODavid A. Baron, MSEd, DO (Moderator)
Professor, Department of Psychiatry
Keck School of Medicine
University of Southern California
Chief of Psychiatry, University Hospital
Director, Global Center for Exercise, Psychiatry and Sport at USC
Vice Chair, Department of Psychiatry
Los Angeles, CA

David W. Goodman, MDDavid W. Goodman, MD 
Director, Adult Attention Deficit Disorder Center of Maryland
Lutherville, MD
Assistant Professor, Department of Psychiatry and Behavioral Sciences
Johns Hopkins University
Baltimore, MD

James McCracken, MDJames McCracken, MD 
Joseph Campbell Professor of Child Psychiatry and Director
Division of Child and Adolescent Psychiatry
Semel Institute and David Geffen School of Medicine
Staff Physician at Resnick Neuropsychiatric Hospital
University of California at Los Angeles
Los Angeles, CA

Statement of Need

One of the common misconceptions about ADHD is that it occurs only in children. The reality is that ADHD can affect people of all ages. It is estimated that in the United States alone, nearly 8 million adults have ADHD. While inattentiveness, impulsivity, and hyperactivity are the same hallmark features of both child and adult ADHD, these symptoms often manifest quite differently in adults. For example, hyperactivity in the child may be excessive running and climbing, while in the adult it is driving too fast. Impulsivity in the child can show up as blurting out answers in class, whereas for the adult interrupting colleagues during a business meeting would be likely. Recognition of the symptoms of ADHD that impact everyday life—at home, at work, and socially—is critical. The good news is that adult ADHD is a treatable medical condition, when recognized and addressed with an eye toward optimal management. Current data suggests that further continuing education and professional development is warranted to address clinical practice gaps related to diagnosis and management of ADHD in adults. In this neuroscienceCME Live and On Demand activity, expert faculty will explore best evidence to help clinicians achieve best practice as it relates to assessment, diagnosis, and management of adult ADHD.


  • Davidson MA. ADHD in adults: a review of the literature. J Atten Disord 2008;11:628-641.
  • Newcorn JH, Weiss M, Stein MA. The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities. CNS Spectr 2007;12(Suppl 12):1-14.

Activity Goal

To improve knowledge and performance through translation of best available evidence pertaining to adult ADHD diagnosis and management, given the absence of practice guidelines.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Increase clinical suspicion and screening for adult ADHD to improve detection rates.
  • Apply criteria to definitively diagnose adult ADHD and potential comorbid conditions.
  • Develop a strategy for tailoring individualized, comprehensive treatment plans using the best available evidence, given the absence of practice guidelines.

The following learning objectives pertain only to those requesting CNE credit:

  • Recognize the signs of adult ADHD.
  • Identify criteria to definitively diagnose adult ADHD and potential comorbid conditions.
  • Compare and contrast options for a comprehensive treatment plan using the best available evidence given the absence of practice guidelines.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, pharmacists, and other healthcare professionals interested in diagnosis and management of adults with ADHD.

Financial Support

This educational activity is supported by an independent medical educational grant from Shire.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

It has been assigned approval code 7ZDR8F-10. 1.0 contact hours will be awarded upon successful completion.

CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 376-000-09-032-L01-P (live presentation) 376-000-09-032-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations can be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab–requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4–6 weeks to all who successfully complete these requirements. This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Baron has disclosed that he receives grants from the National Institute on Drug Abuse and the National Institute of Mental Health. He serves as a consultant to California Academy of Family Physicians, Eli Lilly and Company, Singapore Institute of Mental Health, and University of Cairo. He is also on the Data Monitoring Team of Pharmaceutical Product Development, Inc. (PPD).

Dr. Goodman has disclosed that he receives research grants from Cephalon, Inc., Eli Lilly and Company, Forest Laboratories, Inc., New River Pharmaceuticals, Inc., Ortho-McNeil, and Shire Pharmaceuticals. He receives honoraria from the American Professional Society of ADHD and Related Disorders, Audio-Digest Foundation, CME Inc, Eli Lilly and Company, Excepta Medica, Forest Laboratories, Inc., JB Ashton Associates, Medscape, Neuroscience Education Institute, Ortho-McNeil, Shire Pharmaceuticals, Synermed Communications, Temple University, Veritas Institute, WebMD, and Wyeth Pharmaceuticals. Dr. Goodman is on the speakers bureaus of Forest Laboratories, Inc., McNeil Pediatrics, Shire Pharmaceuticals, and Wyeth Pharmaceuticals. He serves as a consultant to Avacat, Clinical Global Advisors, Eli Lilly and Company, Forest Laboratories, Inc., Ortho-McNeil, New River Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Schering-Plough Corporation, Shire Pharmaceuticals, and Thomson Reuters, and receives royalties from MBL Communications.

Dr. McCracken has disclosed that he receives grants from Aspect Medical Systems, Inc., Bristol-Myers Squibb Company, and Seaside Pharmaceutical, Inc. He serves as a consultant to BioMarin Pharmaceutical Inc. and Novopharm.

Howard Bliwise, MD (Content/Peer Reviewer) has no disclosures to report.
Nancy Jennings, MSN, MBA, MHA, RNC (Content/Peer Reviewer) has no disclosures to report.
Ruth Cody, BSN, RN-BC (Content/Peer Reviewer) has no disclosures to report.
Philip Harvey, PhD (Content/Peer Reviewer) has no disclosures to report.
Greg Kirk, MSW, LCSW (Content/Peer Reviewer) has no disclosures to report.

Monique Johnson, MD, CCMEP (Planning Committee) has no disclosures to report.
Sharon Tordoff, CCMEP (Planning Committee) has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, and Shire Pharmaceuticals do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

TV-063-120209-19

Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download